Stability indicating method for sodium montelukast in pharmaceutical preparations by micellar electrokinetic capillary chromatography

Pharmazie

Volumn 65, Issue 9, 2010, Pages 645-649

  Roman, J ^a   Malesuik, M D ^a   Jablonski, A ^a   Steppe, M ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST;

ACCURACY; ARTICLE; DRUG COATING; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC POTENTIAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ACETATES; BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; DRUG STABILITY; ELECTROCHEMISTRY; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; LEUKOTRIENE ANTAGONISTS; QUINOLINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS; TABLETS;

EID: 77957975213     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0055     Document Type: Article

References (22)

1. Al-Omari M, Zoubi R, Hasan E, Knader T, Badwan A (2007) Effect of light and heat on the stability of montelukast in solution and its solid state. J Pharm Biomed Anal 45: 465-471.
2. Al-Rawithi S, Al-Gazlan S, Al-Ahmadi W, Alshowaier I, Yusuf A, Raines D (2001) Expedient liquid chromatography method with fluorescence detection for montelukast sodium in micro-samples of plasma. J Chromatogr B 754: 527-531.
3. Alsarra IA (2004) Development of a stability-indicating HPLC method for the determination of montelukast in tablets and human plasma and its applications to pharmacokinetic and stability studies. Saudi Pharm J 12: 136-143.
4. Alsarra I, Khalil NY, Sultan M (2005) Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma. Pharmazie 60: 823-826. (Pubitemid 41704157)
5. Altria KD (1996) Micellar Electrokinetic Chromatography. In: Human Press (ed.) Applications of capillary electrophoresis and specific tecnologies, Totowa, p. 125-156.
6. Hoang TH, Sharma R, Susanto D, Di Maso M, Kwong E (2007) Microwave-assisted extraction of active pharmaceutical ingredient from solid dosage forms. J Chromatogr A 1156: 149-154.
7. ICH (2003) In: International conference on Harmonization of technical requirements for registration of pharmaceuticals for human use, Stability testing of new drug substance and products Q1A(R2), Switzerland.
8. ICH (2005) In: International conference on Harmonization of technical requirements for registration of pharmaceuticals for human use, Validation of analytical procedures: Text and Methodology Q2(R1), Switzerland.
9. Kitchen J, Wang Q, Musson G, Yang Y, Fisher L (2003) A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection. J Pharm Biomed Anal 31: 647-654.
10. Liu LD, Cheng HY, Zhao JJ (1997) Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J Pharm Biomed Anal 15: 631-638.
11. Mayer BX (2001) How to increase precision in capillary electrophoresis. J Chromatogr A 907: 21-37.
12. Migoya E, Kearns L, Hartford A, Zhao J, Adelsberg J, Tozzi C, Knorr B, Deutsch P (2004) Pharmacokicetics of montelukast in asthmatic patients 6 and 24 months old. J Clin Pharmacol 44: 487-494. (Pubitemid 38509717)
13. Ochiai H, Uchyama N, Takamo T (1998) Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection. J Chromatogr B 713: 409-414.
14. Overbeek E, O'Sullivan S, Leman K, Mulder H, Hoogsteden C, Prins B (2004) Effect of montelukast compared whith inhaled fluticasone on airway inflammation. J allergy Clin Immun 34: 1388-1394.
15. Papp R, Luk P, Mullett W, Kwong E (2007) A rapid and sensitive method for the quantitation of montelukast in sheep plasma using liquid chromatography/tandem mass spectrometry. J Chromatogr B 858: 282-286.
16. Pereira EA, Micke GA, Tavares FM (2005) Determination of antiretroviral agents in human serum by capillary electrophoresis. J Chromatogr A 1096: 169-176.
17. Radhakrishna T, Narasaraju A, Ramakrishna M, Satyanarayana A (2002) Simultaneus determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J Pharm Biomed Anal 31: 359-368.
18. Ramakrishnan R, Migoya E, Knorr B (2005) A population pharmacokinetic model for montelukast disposition in adults and children. Pharm Res 22: 532-540.
19. Shakalisava Y, Regan F (2008) Determination of montelukast sodium by capillary electrophoresis. J Sep Sci 31: 1137-1143.
20. Smith A, Rawls M, Kunka L (2004) An automated method for the determination of montelukast in human plasma using dual-colunn HPLC analysis and peak height summation of the parent compound and its photodegradation product. Pharm Res 21: 1539-1544.
21. Spector S (2001) Safety of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol 86: 18-23.
22. th (2007) Rockville MD.